Australia, Feb. 12 -- Mirador Therapeutics Inc., owns the trademark (2502439) for 'MIRADOR' till May 7, 2034.
Status: protected:
Registered/protected
Classes: 1 [Chemical substances, chemical materials and chemical preparations; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines.], 5 [Pharmaceutical preparations; diagnostic preparations for medical purposes; monoclonal antibodies; chemical, biological and biochemical reagents for medical or veterinary purposes; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents.], 10 [Medical devices.], 42 [Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; pharmaceutical research and development of pharmaceutical preparations; research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; laboratory research services in connection with developing new medicinal products; scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics.], 44 [Medical services.], 01 [], 05 [], 10 [], 42 [] and 44 []
Type of Mark: Word
Date of Acceptance: Dec. 4, 2024
Registration Advertised: Feb. 11
For further details contact Brent D. Sokol Greenberg Traurig LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2502439.
Disclaimer: Curated by HT Syndication.
